Ming Chen

Trích dẫn bởi

	Tất cả	Từ 2020
Trích dẫn	3177	2146
h-index	23	19
i10-index	32	22

480

240

120

360

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202516 24 31 41 21 51 46 27 47 38 55 65 59 82 130 271 369 466 433 377 412 89

Truy cập công khai

Xem tất cả

30 bài viết

2 bài viết

có sẵn

không có sẵn

Dựa trên yêu cầu tài trợ

Đồng tác giả

Pier Paolo PandolfiDirector, Cancer Center and Cancer Research Institute, Beth Israel Deaconess Medical CenterEmail được xác minh tại bidmc.harvard.edu
Jiaoti HuangDuke University School of medicineEmail được xác minh tại duke.edu
Sabina SignorettiProfessor, Brigham and Women's Hospital, Harvard Medical SchoolEmail được xác minh tại bwh.harvard.edu
John AsaraAssociate Professor Medicine, Harvard Medical School; Director, Beth Israel Deaconess Medical CenterEmail được xác minh tại bidmc.harvard.edu
Jiangwen ZhangUniversity of Hong KongEmail được xác minh tại hku.hk
Carlos Cordon-CardoChair, Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at MountEmail được xác minh tại mssm.edu
Mireia Castillo-MartinEmail được xác minh tại research.fchampalimaud.org
YU-RU LEEInstitute of Biomedical Sciences, Academia SinicaEmail được xác minh tại ibms.sinica.edu.tw
Lourdes MendezEmail được xác minh tại bidmc.harvard.edu
Antonella PapaCancer Biology and Cell Signalling Lab - Monash UniversityEmail được xác minh tại monash.edu
Wenyi WeiProfessor, Dept. of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical SchoolEmail được xác minh tại bidmc.harvard.edu
Jinfang ZhangInstructor, Beth Israel Deaconess Medical Center, Harvard Medical SchoolEmail được xác minh tại bidmc.harvard.edu
Andrew WolfeAssociate Professor of Pediatrics, Johns Hopkins UniversityEmail được xác minh tại jhmi.edu
Lixin WanH. Lee Moffitt Cancer Center and Research InstituteEmail được xác minh tại moffitt.org
Mesut MuyanMiddle East Technical UniversityEmail được xác minh tại metu.edu.tr
Andrew J. ArmstrongProfessor, Duke UniversityEmail được xác minh tại duke.edu
Yuzhuo Wang, Ph.D. FCAHSProfessor of Urologic Sciences, UBCEmail được xác minh tại bccrc.ca
Leonardo SalmenaUniversity of TorontoEmail được xác minh tại utoronto.ca
Qianben Wang, Ph.D.Banks Anderson, Sr. Distinguished Professor of Pathology, Duke University School of MedicineEmail được xác minh tại duke.edu
Leszek KotulaUpstate Medical University, Syracuse, NYEmail được xác minh tại upstate.edu

Theo dõi

Ming Chen

Associate Professor in Pathology, Duke University School of Medicine, Duke Cancer Institute

Email được xác minh tại duke.edu - Trang chủ

PTEN metastasis lipid metabolism ferroptosis mouse models


Tiêu đề Sắp xếp theo số lượt trích dẫn Sắp xếp theo năm Sắp xếp theo tiêu đề	Trích dẫn bởi Trích dẫn bởi	Năm
The functions and regulation of the PTEN tumour suppressor: new modes and prospects YR Lee, M Chen, PP Pandolfi Nature reviews Molecular cell biology 19 (9), 547-562, 2018	815	2018
An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer M Chen, J Zhang, K Sampieri, JG Clohessy, L Mendez, ... Nature genetics 50 (2), 206-218, 2018	294	2018
Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway YR Lee, M Chen, JD Lee, J Zhang, SY Lin*, TM Fu, H Chen, T Ishikawa, ... Science 364 (6441), 2019	274	2019
Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery J Ni, M Chen, Y Zhang, R Li, J Huang, S Yeh Biochemical and biophysical research communications 300 (2), 357-363, 2003	182	2003
Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms M Bezzi, N Seitzer, T Ishikawa*, M Reschke, M Chen, G Wang, ... Nature medicine 24 (2), 165-175, 2018	168	2018
The expanded role of fatty acid metabolism in cancer: new aspects and targets M Chen, J Huang Precision clinical medicine 2 (3), 183-191, 2019	164	2019
In vivo role of INPP4B in tumor and metastasis suppression through regulation of PI3K–AKT signaling at endosomes CL Chew, A Lunardi, F Gulluni, DT Ruan, M Chen, L Salmena, ... Cancer discovery 5 (7), 740-751, 2015	113	2015
Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway J Ni, X Wen, J Yao, HC Chang, Y Yin, M Zhang, S Xie, M Chen, B Simons, ... Cancer research 65 (21), 9807-9816, 2005	113	2005
Vulnerabilities of PTEN–TP53-Deficient Prostate Cancers to Compound PARP–PI3K Inhibition E González-Billalabeitia, N Seitzer, SJ Song, MS Song, A Patnaik, XS Liu, ... Cancer discovery 4 (8), 896-904, 2014	102	2014
Defects of prostate development and reproductive system in the estrogen receptor-α null male mice M Chen, I Hsu, A Wolfe, S Radovick, KH Huang, S Yu, C Chang, ... Endocrinology 150 (1), 251-259, 2009	90	2009
The APC/C E3 ligase complex activator FZR1 restricts BRAF oncogenic function L Wan, M Chen, J Cao, X Dai, Q Yin*, J Zhang, SJ Song, Y Lu, J Liu, ... Cancer discovery 7 (4), 424-441, 2017	72	2017
CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells M Chen, J Ni, HC Chang, CY Lin, M Muyan, S Yeh Carcinogenesis 30 (5), 841-850, 2009	70	2009
SPOP promotes nanog destruction to suppress stem cell traits and prostate cancer progression J Zhang, M Chen, Y Zhu*, X Dai, F Dang, J Ren, S Ren, YV Shulga, ... Developmental cell 48 (3), 329-344. e5, 2019	68	2019
RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis ME Wang, J Chen, Y Lu, AR Bawcom, J Wu, J Ou, JM Asara, ... The Journal of clinical investigation 133 (10), 2023	56	2023
Generation and characterization of a complete null estrogen receptor α mouse using Cre/LoxP technology M Chen, A Wolfe, X Wang, C Chang, S Yeh, S Radovick Molecular and cellular biochemistry 321 (1), 145-153, 2009	55	2009
Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism M Chen, L Wan, J Zhang, J Zhang, L Mendez, JG Clohessy, K Berry, ... Nature communications 9 (1), 159, 2018	54	2018
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling D Nath, X Li, C Mondragon, D Post, M Chen, JR White, ... Cell Communication and Signaling 17, 1-19, 2019	47	2019
Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis A Lunardi, S Varmeh, M Chen, R Taulli, J Guarnerio, U Ala, N Seitzer, ... Cancer discovery 5 (5), 550-563, 2015	46	2015
Ornithine decarboxylase is sufficient for prostate tumorigenesis via androgen receptor signaling A Shukla-Dave, M Castillo-Martin, M Chen, J Lobo, N Gladoun, ... The American journal of pathology 186 (12), 3131-3145, 2016	44	2016
Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy V Mugoni, R Panella, G Cheloni, M Chen*, O Pozdnyakova, ... Cell research 29 (6), 446-459, 2019	43	2019

Hệ thống không thể thực hiện thao tác ngay bây giờ. Hãy thử lại sau.

Bài viết 1–20

Trích dẫn mỗi năm

Trích dẫn trùng lặp

Trích dẫn được hợp nhất

Thêm đồng tác giảĐồng tác giả

Theo dõi

Trích dẫn bởi

Đồng tác giả